Patricia M. Drake

CIK 1865279 · SVP, Chief Commercial Officer · last filed 2023-12-15

Patricia M. Drake is a SVP, Chief Commercial Officer who has filed 9 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for TRVN, was dated Dec 15, 2023. Current disclosed insider exposure totals $931 across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$931

Companies

2

Total Filings

9

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TRVN SVP, Chief Commercial Officer 83,913 $0.01 $931 $0 8 2023-12-15
Carisma Therapeutics Inc. (SESN) Delisted Chief Commercial Officer $12.58 $0 1 2021-06-03

Recent Filings

9 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-12-15 TRVN Mixed +73,165 $44.6K EDGAR
2023-12-05 TRVN Tax (F) −2,129 -$1.3K EDGAR
2023-11-14 TRVN Tax (F) −632 -$360 EDGAR
2023-01-06 TRVN Grant (A) +25,000 $0 EDGAR
2022-12-06 TRVN Tax (F) −294 -$1.0K EDGAR
2022-11-15 TRVN Tax (F) −632 -$1.6K EDGAR
2021-12-03 TRVN Grant (A) +100,000 $0 EDGAR
2021-11-12 TRVN Grant (A) +215,000 $0 EDGAR
2021-06-03 Carisma Therapeutics Inc. (SESN) Delisted Grant (A) $0 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.